Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Mar 15, 2020; 12(3): 276-288
Published online Mar 15, 2020. doi: 10.4251/wjgo.v12.i3.276
Published online Mar 15, 2020. doi: 10.4251/wjgo.v12.i3.276
Figure 7 KIF21B expression in hepatocellular carcinoma tissues and normal adjacent tissues.
A and B: Low expression of KIF21B in normal adjacent tissues (magnification: ×100 for A and ×400 for B); C and D: High expression of KIF21B in hepatocellular carcinoma tissues (magnification: ×100 for C and ×400 for D); E and F: Kaplan-Meier’s survival curves using a log-rank test demonstrating the correlation between KIF21B expression and overall survival or disease-free survival. Dashed lines indicate high KIF21B expression, and solid lines indicate low KIF21B expression.
- Citation: Zhao HQ, Dong BL, Zhang M, Dong XH, He Y, Chen SY, Wu B, Yang XJ. Increased KIF21B expression is a potential prognostic biomarker in hepatocellular carcinoma. World J Gastrointest Oncol 2020; 12(3): 276-288
- URL: https://www.wjgnet.com/1948-5204/full/v12/i3/276.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i3.276